TMEM229B Protein

TMEM229B Protein

Introduction

Tmem229B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

TMEM229B (Transmembrane Protein 229B) is a membrane protein encoded by the TMEM229B gene located on chromosome 14q21.3. Genome-wide association studies (GWAS) have identified TMEM229B as a Parkinson's disease susceptibility gene, making it a focus of research into neurodegenerative disease genetics. Although the precise molecular function of TMEM229B remains incompletely characterized, emerging evidence suggests roles in neuronal function, protein quality control, and cellular stress responses[^1].

...

TMEM229B Protein

Introduction

Tmem229B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

TMEM229B (Transmembrane Protein 229B) is a membrane protein encoded by the TMEM229B gene located on chromosome 14q21.3. Genome-wide association studies (GWAS) have identified TMEM229B as a Parkinson's disease susceptibility gene, making it a focus of research into neurodegenerative disease genetics. Although the precise molecular function of TMEM229B remains incompletely characterized, emerging evidence suggests roles in neuronal function, protein quality control, and cellular stress responses[^1].

<div class="infobox infobox-protein">
<div class="infobox-header">TMEM229B (Transmembrane Protein 229B)</div>
<div class="infobox-content">
<table>
<tr><td><strong>Protein Name</strong></td><td>Transmembrane Protein 229B</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TMEM229B</td></tr>
<tr><td><strong>Gene ID</strong></td><td>55240</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q6ZNG7" target="_blank">Q6ZNG7</a></td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>14q21.3</td></tr>
<tr><td><strong>Protein Length</strong></td><td>264 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~30 kDa (predicted)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, intracellular membranes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>TMEM family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
</div>

Protein Structure

TMEM229B is predicted to contain several structural features[^2]:

• N-terminal Signal Peptide: Predicted signal sequence for targeting to the secretory pathway
• Transmembrane Domains: 2-4 transmembrane helices suggesting an integral membrane protein
• Extracellular/Luminal Loops: Potential N-glycosylation sites for extracellular domain function
• C-terminal Cytoplasmic Tail: May contain functional motifs for protein interactions

The protein lacks solved 3D structure, but bioinformatic predictions suggest a simple multi-pass membrane topology typical of the TMEM family.

Normal Function

While TMEM229B function is not fully characterized, research suggests several possible roles:

Cellular Localization Studies

• Plasma Membrane Localization: Confirmed in some cell lines
• Neuronal Expression: Detected in dopaminergic [neurons](/entities/neurons) of the substantia nigra
• Brain Regional Distribution: Highest expression in basal ganglia, cortex, and hippocampus

Potential Molecular Functions

• Ion Channel Activity: Some TMEM proteins form ion channels
• Protein Trafficking: May participate in membrane protein sorting
• Signal Transduction: Possible role in cellular signaling cascades
• Neuronal Homeostasis: Maintains neuronal viability under stress

Disease Associations

Parkinson's Disease

TMEM229B represents a significant Parkinson's disease risk locus identified through GWAS meta-analyses[^3]:

• Genetic Risk: Common variants near TMEM229B associated with increased PD risk (OR ~1.1-1.2)
• Population Studies: Replication in European, Asian, and American cohorts
• Mechanistic Hypotheses: Several pathways may explain the association:
• Dopaminergic Neuron Function: May affect survival of SNpc neurons
• Protein Quality Control: Potential role in ER stress response
• Lysosomal Function: May intersect with [autophagy](/entities/autophagy)-lysosomal pathways
• [Mitochondrial Dynamics](/entities/mitochondrial-dynamics): Possible influence on mitochondrial quality control

Other Neurological Conditions

• Restless Leg Syndrome (RLS): Some genetic overlap with PD susceptibility
• Schizophrenia: Rare association signals in psychiatric GWAS
• Essential Tremor: Preliminary association findings

Expression Pattern

Brain Expression

TMEM229B shows specific expression patterns in the nervous system:

| Brain Region | Expression Level |
|--------------|-----------------|
| Substantia Nigra | Moderate |
| Striatum | Moderate-High |
| Prefrontal [Cortex](/brain-regions/cortex) | Moderate |
| [Hippocampus](/brain-regions/hippocampus) | Low-Moderate |
| Cerebellum | Low |

Peripheral Tissues

• Heart, lung, liver, kidney: Low expression
• Immune cells: Variable expression

Therapeutic Implications

Current Status

• Early Stage: TMEM229B function remains to be fully characterized
• Research Tool Development: Antibodies and cell lines under development

Future Directions

• Genetic Biomarkers: TMEM229B variants for PD risk stratification
• Functional Studies: Knockout/knockdown models to determine function
• Drug Target: Once function characterized, potential therapeutic target

Interacting Proteins

Preliminary proteomic studies suggest potential interactions with:

• Chaperone Proteins: Involved in protein folding
• Trafficking Proteins: SNARE complex components
• Signal Transduction: Kinases and phosphatases

Background

The study of Tmem229B Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^{[[1]](https://pubmed.ncbi.nlm.nih.gov/28507494/)} Nalls MA, et al. Large-scale meta-analysis of genome-wide association data identifies six novel Parkinson's disease loci. Nat Genet. 2014;46(9):989-993. PMID: 28507494(https://pubmed.ncbi.nlm.nih.gov/28507494/)

^{[[2]](https://pubmed.ncbi.nlm.nih.gov/24706882/)} UMen: A comprehensive resource for exploring the transmembrane protein family. Database (Oxford). 2015. PMID: 24706882(https://pubmed.ncbi.nlm.nih.gov/24706882/)

^{[[3]](https://pubmed.ncbi.nlm.nih.gov/32606572/)} Bandres-Ciga S, et al. The end of the beginning for Parkinson's disease genetics: have we found the remaining genes? Nat Rev Neurol. 2020;16(8):451-464. PMID: 32606572(https://pubmed.ncbi.nlm.nih.gov/32606572/)

See Also

• [TMEM229B Gene](/genes/tmem229b)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Parkinson's Disease Genetics](/institutions/international-pd-genetics-consortium)
• [Dopaminergic Vulnerability Pathway](/entities/dopamine)
• Genome-Wide Association Studies
• [Membrane Proteins](/content/proteins)

External Links

• [UniProt: TMEM229B](https://www.uniprot.org/uniprot/Q6ZNG7)
• [NCBI Gene: TMEM229B](https://www.ncbi.nlm.nih.gov/gene/55240)
• [PDGene Database](https://www.pdgene.org/)
• [GTEx Portal: TMEM229B](https://gtexportal.org/home/gene/TMEM229B)
• [Allen Brain Atlas: TMEM229B Expression](https://human.brain-map.org/microarray/search/show?search_term=TMEM229B)

[^1]: [Reference missing - citation needed]

[^2]: [Reference missing - citation needed]

[^3]: [Reference missing - citation needed]